153 related articles for article (PubMed ID: 12963984)
1. Over-expression of bone sialoprotein enhances bone metastasis of human breast cancer cells in a mouse model.
Zhang JH; Tang J; Wang J; Ma W; Zheng W; Yoneda T; Chen J
Int J Oncol; 2003 Oct; 23(4):1043-8. PubMed ID: 12963984
[TBL] [Abstract][Full Text] [Related]
2. Bone sialoprotein promotes bone metastasis of a non-bone-seeking clone of human breast cancer cells.
Zhang JH; Wang J; Tang J; Barnett B; Dickson J; Hahsimoto N; Williams P; Ma W; Zheng W; Yoneda T; Pageau S; Chen J
Anticancer Res; 2004; 24(3a):1361-8. PubMed ID: 15274296
[TBL] [Abstract][Full Text] [Related]
3. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.
Mbalaviele G; Dunstan CR; Sasaki A; Williams PJ; Mundy GR; Yoneda T
Cancer Res; 1996 Sep; 56(17):4063-70. PubMed ID: 8752180
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of bone sialoprotein in bone metastases compared with visceral metastases in human breast and prostate cancers.
Waltregny D; Bellahcène A; de Leval X; Florkin B; Weidle U; Castronovo V
J Bone Miner Res; 2000 May; 15(5):834-43. PubMed ID: 10804012
[TBL] [Abstract][Full Text] [Related]
5. Bone sialoprotein stimulates focal adhesion-related signaling pathways: role in migration and survival of breast and prostate cancer cells.
Gordon JA; Sodek J; Hunter GK; Goldberg HA
J Cell Biochem; 2009 Aug; 107(6):1118-28. PubMed ID: 19492334
[TBL] [Abstract][Full Text] [Related]
6. Early detection of bone metastases in a murine model using fluorescent human breast cancer cells: application to the use of the bisphosphonate zoledronic acid in the treatment of osteolytic lesions.
Peyruchaud O; Winding B; Pécheur I; Serre CM; Delmas P; Clézardin P
J Bone Miner Res; 2001 Nov; 16(11):2027-34. PubMed ID: 11697798
[TBL] [Abstract][Full Text] [Related]
7. Treatment of bone metastasis induced by MDA-MB-231 breast cancer cells with an antibody against bone sialoprotein.
Bäuerle T; Peterschmitt J; Hilbig H; Kiessling F; Armbruster FP; Berger MR
Int J Oncol; 2006 Mar; 28(3):573-83. PubMed ID: 16465361
[TBL] [Abstract][Full Text] [Related]
8. Tumor cells are the source of osteopontin and bone sialoprotein expression in human breast cancer.
Sharp JA; Sung V; Slavin J; Thompson EW; Henderson MA
Lab Invest; 1999 Jul; 79(7):869-77. PubMed ID: 10418827
[TBL] [Abstract][Full Text] [Related]
9. Bone sialoprotein expression in primary human breast cancer is associated with bone metastases development.
Bellahcene A; Kroll M; Liebens F; Castronovo V
J Bone Miner Res; 1996 May; 11(5):665-70. PubMed ID: 9157781
[TBL] [Abstract][Full Text] [Related]
10. Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo.
Bendre MS; Gaddy-Kurten D; Mon-Foote T; Akel NS; Skinner RA; Nicholas RW; Suva LJ
Cancer Res; 2002 Oct; 62(19):5571-9. PubMed ID: 12359770
[TBL] [Abstract][Full Text] [Related]
11. Detection of bone sialoprotein in human breast cancer tissue and cell lines at both protein and messenger ribonucleic acid levels.
Bellahcène A; Antoine N; Clausse N; Tagliabue E; Fisher LW; Kerr JM; Jarès P; Castronovo V
Lab Invest; 1996 Aug; 75(2):203-10. PubMed ID: 8765320
[TBL] [Abstract][Full Text] [Related]
12. Bone sialoprotein promotes tumor cell migration in both in vitro and in vivo models.
Chen J; Rodriguez JA; Barnett B; Hashimoto N; Tang J; Yoneda T
Connect Tissue Res; 2003; 44 Suppl 1():279-84. PubMed ID: 12952209
[TBL] [Abstract][Full Text] [Related]
13. CREB-1 and AP-1 transcription factors JunD and Fra-2 regulate bone sialoprotein gene expression in human breast cancer cells.
Detry C; Lamour V; Castronovo V; Bellahcène A
Bone; 2008 Feb; 42(2):422-31. PubMed ID: 18088579
[TBL] [Abstract][Full Text] [Related]
14. Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer.
Palmieri D; Halverson DO; Ouatas T; Horak CE; Salerno M; Johnson J; Figg WD; Hollingshead M; Hursting S; Berrigan D; Steinberg SM; Merino MJ; Steeg PS
J Natl Cancer Inst; 2005 May; 97(9):632-42. PubMed ID: 15870434
[TBL] [Abstract][Full Text] [Related]
15. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
Nemeth JA; Harb JF; Barroso U; He Z; Grignon DJ; Cher ML
Cancer Res; 1999 Apr; 59(8):1987-93. PubMed ID: 10213511
[TBL] [Abstract][Full Text] [Related]
16. Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis.
Diel IJ; Solomayer EF; Seibel MJ; Pfeilschifter J; Maisenbacher H; Gollan C; Pecherstorfer M; Conradi R; Kehr G; Boehm E; Armbruster FP; Bastert G
Clin Cancer Res; 1999 Dec; 5(12):3914-9. PubMed ID: 10632320
[TBL] [Abstract][Full Text] [Related]
17. Analysis of human bone sialoprotein in normal and pathological tissues using a monoclonal antibody (BSP 1.2 mab).
Cogan G; Bansal AK; Ibrahim S; Zhu B; Goldberg HA; Ganss B; Cheifetz S; Armbruster FP; Sodek J
Connect Tissue Res; 2004; 45(1):60-71. PubMed ID: 15203941
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions.
Feeley BT; Krenek L; Liu N; Hsu WK; Gamradt SC; Schwarz EM; Huard J; Lieberman JR
Bone; 2006 Feb; 38(2):154-66. PubMed ID: 16126463
[TBL] [Abstract][Full Text] [Related]
19. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
Li Y; Tang Y; Ye L; Liu B; Liu K; Chen J; Xue Q
J Cancer Res Clin Oncol; 2003 Jan; 129(1):43-51. PubMed ID: 12618900
[TBL] [Abstract][Full Text] [Related]
20. Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice.
Sasaki A; Boyce BF; Story B; Wright KR; Chapman M; Boyce R; Mundy GR; Yoneda T
Cancer Res; 1995 Aug; 55(16):3551-7. PubMed ID: 7627963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]